Additional information
White powder
1402053-59-1
ACI-036414
145.9-148.8°C
C14H20N2O4
280.32
Ambient
2-8°C
Neurodegenerative
Pharmaceutical Impurity Standards
(S)-methyl 2-(2-(propan-2-ylidene)hydrazinyl)-2-(3,4-dihydroxybenzyl)propanoate
(S)-methyl 2-(2-(propan-2-ylidene)hydrazinyl)-2-(3,4-dihydroxybenzyl)propanoate
Benzenepropanoic acid, 3,4-dihydroxy-?-methyl-?-[2-(1-methylethyl)diazenyl]-, methyl ester, (?S)





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)